Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

HAEMONETICS CORP Director's Dealing 2010

Mar 24, 2010

31565_dirs_2010-03-24_163249e1-f2ee-4e94-beb3-bc56d4c5c3a2.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: HAEMONETICS CORP (HAE)
CIK: 0000313143
Period of Report: 2010-03-22

Reporting Person: NUTTER BRAD (Director, Chairman of the Board)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2010-03-22 Common Stock M 142328 $41.15 Acquired 151715 Direct
2010-03-22 Common Stock S 142328 $57 Disposed 9387 Direct
2010-03-23 Common Stock M 30700 $41.15 Acquired 40087 Direct
2010-03-23 Common Stock S 30700 $57.0002 Disposed 9387 Direct
2010-03-24 Common Stock M 100 $41.15 Acquired 9487 Direct
2010-03-24 Common Stock S 100 $57 Disposed 9387 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2010-03-22 Non-Qualified Stock Option (right to buy) $41.15 M 142328 Disposed 2012-07-27 Common Stock (142328) Direct
2010-03-23 Non-Qualified Stock Option (right to buy) $41.15 M 30700 Disposed 2012-07-27 Common Stock (30700) Direct
2010-03-24 Non-Qualified Stock Option (right to buy) $41.15 M 100 Disposed 2012-07-27 Common Stock (100) Direct

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Non-Qualified Stock Option (right to buy) $52.76 2013-05-05 Common Stock (200000) 200000 Direct
Non-Qualified Stock Option (right to buy) $54.55 2015-10-22 Common Stock (64324) 64324 Direct
Non-Qualified Stock Option (right to buy) $59.44 2016-07-30 Common Stock (5879) 5879 Direct

Footnotes

F1: Pursuant to a 10b5-1 Plan.

F2: Total includes Restricted Stock Awards and/or Restricted Stock Units that are subject to restrictions until vesting requirements are met. Grant was made under 2005 Long Term Incentive Compensation Plan.

F3: Grant to reporting person of right to buy shares of common stock exercisable in annual increments of 25 percent beginning on the first anniversary of the date of grant.

F4: Grant to reporting person of right to buy shares of common stock exercisable 100 percent on the first anniversary of the date of grant.